252 related articles for article (PubMed ID: 12105835)
1. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
[TBL] [Abstract][Full Text] [Related]
2. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
3. Discussion on the effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Cattan D
Gastroenterology; 2003 Aug; 125(2):627; author reply 627-8. PubMed ID: 12891576
[No Abstract] [Full Text] [Related]
4. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
5. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
[TBL] [Abstract][Full Text] [Related]
6. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
7. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
9. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C
Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627
[TBL] [Abstract][Full Text] [Related]
10. Expression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia.
Bordi C; Pilato FP; Bertelé A; D'Adda T; Missale G
Hum Pathol; 1988 May; 19(5):580-5. PubMed ID: 2453443
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of ECL cell tumors in humans.
Bordi C; D'Adda T; Azzoni C; Ferraro G
Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
13. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
Annibale B; Aprile MR; D'ambra G; Caruana P; Bordi C; Delle Fave G
Aliment Pharmacol Ther; 2000 May; 14(5):625-34. PubMed ID: 10792127
[TBL] [Abstract][Full Text] [Related]
14. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
15. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth.
Ferraro G; Annibale B; Marignani M; Azzoni C; D'Adda T; D'Ambra G; Bordi C; delle Fave G
J Clin Endocrinol Metab; 1996 Feb; 81(2):677-83. PubMed ID: 8636288
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of ECL-cell abnormalities.
Hirschowitz BI
Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
[TBL] [Abstract][Full Text] [Related]
18. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
Lehy T; Roucayrol AM; Mignon M
Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of acid hypersecretion post curative gastrinoma resection.
Ojeaburu JV; Ito T; Crafa P; Bordi C; Jensen RT
Dig Dis Sci; 2011 Jan; 56(1):139-54. PubMed ID: 20725788
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R
Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
